Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and ...

Scientists use a specific type of cell called haematopoietic stem cells, which produce all types of blood cells, including ...

Malabar Cancer Centre (MCC) in Kannur successfully implements CAR T-cell therapy, a groundbreaking treatment for blood cancer ...

Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...

Medically reviewed by Amelia MacIntyre, DO One of the most important characteristics of blood is its type. Knowing your blood ...

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

Immuno-oncology and cell-based treatments, which harness the body's own immune system to combat illnesses like cancer, have ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children, paving ...

People with one of the type A blood groups are more likely to have a stroke before the age of 60 compared with people with other blood types, research shows.